Novartis (NVS)

Add to Watchlists
Create an Alert
90.15 +0.91  +1.02% NYSE Oct 24, 8:00PM BATS Real time Currency in USD

Novartis Return on Equity (TTM):

13.69% for June 30, 2014

View 4,000+ financial data types

View Full Chart

Novartis Return on Equity (TTM) Chart

Export Data
Save Image

Novartis Historical Return on Equity (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 13.69%
March 31, 2014 13.76%
Dec. 31, 2013 13.03%
Sept. 30, 2013 13.24%
June 30, 2013 13.79%
March 31, 2013 14.25%
Dec. 31, 2012 14.08%
Sept. 30, 2012 12.96%
June 30, 2012 13.08%
March 31, 2012 13.11%
Dec. 31, 2011 13.91%
Sept. 30, 2011 15.41%
June 30, 2011 15.61%
March 31, 2011 15.75%
Dec. 31, 2010 16.44%
Sept. 30, 2010 17.24%
June 30, 2010 17.91%
March 31, 2010 17.84%
Dec. 31, 2009 16.30%
Sept. 30, 2009 15.20%
June 30, 2009 15.29%
March 31, 2009 15.80%
Dec. 31, 2008 16.32%
Sept. 30, 2008 15.10%
June 30, 2008 25.35%
   
March 31, 2008 26.05%
Dec. 31, 2007 26.64%
Sept. 30, 2007 29.73%
June 30, 2007 19.13%
March 31, 2007 19.33%
Dec. 31, 2006 19.52%
Sept. 30, 2006 19.72%
June 30, 2006 20.06%
March 31, 2006 20.85%
Dec. 31, 2005 19.70%
Sept. 30, 2005 18.74%
June 30, 2005 18.56%
March 31, 2005 18.37%
Dec. 31, 2004 17.64%
Sept. 30, 2004 18.33%
June 30, 2004 17.98%
March 31, 2004 17.43%
Dec. 31, 2003 16.74%
Sept. 30, 2003 19.46%
June 30, 2003 18.92%
March 31, 2003 19.04%
Dec. 31, 2002 19.59%
Sept. 30, 2002 17.50%
June 30, 2002 18.82%
March 31, 2002

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Get data for
Advertisement

NVS Return on Equity (TTM) Benchmarks

Companies
GlaxoSmithKline 67.58%
Eli Lilly 19.71%
Roche Holding 52.52%

NVS Return on Equity (TTM) Range, Past 5 Years

Minimum 12.96% Sep 2012
Maximum 17.91% Jun 2010
Average 14.81%

NVS Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("NVS", "return_on_equity")
  • Last 5 data points: =YCS("NVS", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.